CRISPR Therapeutics AG is a bio-technology company. The Company researches, develops, and manufactures biological transformative gene-based medicines and other related products. CRISPR Therapeutics operates in Switzerland.

Annual Report to Security Holders (Form ARS | Period ending 2023-12-31)

Annual Report (Form 10-K | Period ending 2023-12-31)

CRISPR Therapeutics AG (CRSP US)

Annual Report to Security Holders (Form ARS | Period ending 2023-12-31)

Annual Report (Form 10-K | Period ending 2023-12-31)

Current Report (Form 8-K | Period ending 2024-02-21)

Statement of changes in beneficial ownership (Form 4 | Period ending 2024-02-15)

424B5 | Prospectus